The power and widespread availability of Next-Generation Sequencing (NGS) platforms, has significantly broadened the scale of many DNA-sequencing (DNA-Seq) applications over the years, from detecting single nucleotide polymorphisms (SNPs) and copy number variations (CNVs), to assembling genomes or transcriptomes, developing quantitative RNA-sequencing (RNA-Seq) analysis, and detecting epigenetic changes. According to the Frontiers in Life Science journal, the current sequencing limit is evaluated to be 13 quadrillion DNA bases per year. This has resulted in the urgent need for new databases that can store large volumes of disparate data types. For example, to store 1,000 human genomes, the net measure of space needed is roughly three terabytes; however, the storage of raw sequences needs considerably more space. Furthermore, retrieving and transferring such voluminous data, which is composed of several thousand genomes (as in the ICGC), requires the use of various sequence compression techniques.
As the research area is expanding rapidly, more libraries are moving towards cloud services; hence, the technology has entered into the second phase of its life cycle dominating the IT paradigm. Therefore, the urge for effectively tackling these data has led to an expanded enthusiasm in approaches toward parallelization and dispersed execution of annotation pipelines. Researchers are expecting to develop an improved version of NGS analytics, which could provide filtering, mapping and analysis of very large datasets in a shorter time span and provide a promisingly accurate and faster capabilities for the analysis of high-throughput sequencing data. This is creating growth opportunities for players to develop effective data storage and NGS analytics solutions. Meticulous Research® in its latest publication on “NGS Services Market – Global Opportunity Analysis and Industry Forecast to 2025” states that the global NGS Services market is expected to grow at a CAGR of 20.5% from 2019 to 2025 to reach $13,107.4 million by 2025.
Growth of the global NGS Services market is mainly attributed to the plummeting cost of sequencing, technological advancements in NGS services, and increase in genome mapping programs. In addition, increasing applications in cancer and agrigenomics research, analysis of complex sequencing data will further provide significant growth opportunities for various stakeholders in this market. However, lack of skilled professionals for efficient NGS sample preparation and analysis is likely to hinder the market growth.
To provide efficient analysis, Meticulous Research® has segmented this market by service type (targeted sequencing, RNA sequencing, exome sequencing, De Novo sequencing, ChIP-sequencing, whole genome sequencing, methyl sequencing, and other services), by technology (sequencing by synthesis, ion semiconductor, single molecule real time sequencing, nanopore sequencing, and true single molecule sequencing), by application (diagnostics, drug discovery, biomarker discovery, agriculture and animal research, and other applications), by end user (hospitals & clinics, pharmaceutical & biotechnology industry, academic & research institutes, and other end users), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
👉 To request a sample copy or view summary of this report, click the link below: https://www.meticulousresearch.com/request-sample-report/cp_id=5041
Market Study –
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.2.1. Plummeting Cost of Sequencing Procedures
4.2.2. Technological Advancements in NGS Services
4.2.3. Increase in Genome Mapping Programs
4.2.4. High Cost of Sequencing Infrastructure
4.3.1. Lack of Skilled Professionals for Efficient NGS Sample Preparation and Analysis
4.4.1. Increasing Applications in Cancer and Agrigenomics Research
4.4.2. Analysis of Complex Sequencing Data
4.5.1. Accuracy & Standardization Concerns in Diagnostic Testing
4.5.2. Installation of In-House Sequencing Facilities in Large Hospitals and Academic Universities
4.5.3. Ethical Issues Related to Non-Invasive Prenatal Testing
5. Next Generation Sequencing Services Market, by Service Type
5.2. Targeted Sequencing
5.3. RNA Sequencing Services
5.4. Exome Sequencing Services
5.5. DE Novo Sequencing Services
5.6. ChIP Sequencing Services
5.7. Whole Genome Sequencing
5.8. Methyl Sequencing
5.9. Other Services
6. Next Generation Sequencing Services Market, by Technology
6.2. Sequencing by Synthesis (SBS)
6.3. Ion Semiconductor Sequencing (IOS)
6.4. Single Molecule Real Time Sequencing (SMRT)
6.5. Nanopore Sequencing
6.6. True Single Molecule Sequencing (tSMS) …Continue
Based on service type, targeted sequencing services commanded the largest share of the global NGS services market in 2018. The high share of targeted sequencing is attributed to its ability to cost effectively & easily isolate and sequence the fragment of genes or region of interest and its increasing adoption for the discovery and development of biomarkers, used to identify the clinically suitable targets in translational research field.
Geographically, North America commanded the largest share of the global NGS services market in 2018, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register highest growth at a CAGR of 22.1% during the forecast period, primarily due to accelerated growth of economies; increasing incidence of infectious and non-communicable diseases with aging population; various government initiatives for genomic research to understand the complex biological process and genetic mutations related to life threatening diseases; increasing investments by the major players; availability of funding; developing healthcare infrastructures; and growing outsourcing activities in the region.
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Illumina, Inc. (U.S.), Qiagen N.V. (The Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Macrogen, Inc. (South Korea), Genotypic Technology Pvt. Ltd. (India), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd. (India), MedGenome (U.S.), DNA Link, Inc. (South Korea), Otogenetics Corporation (U.S.), Novogene Corporation (China), LGC Limited (U.K.), CD Genomics (U.S.), and SeqLL, LLC (U.S.).
👉Here are detail information about top🔟 NGS services companies
Key questions answered in the report-
Increase in genome mapping program in NGS services will propel the NGS services market
How do the increasing genome mapping programs drive the growth of NGS services market?
How government initiatives and investment in genome mapping programs bolstering the NGS services market in developing and developed regions.
Targeted sequencing accounted for the largest share of the NGS services market
What factors are contributing to the frequent usage of targeted sequencing among various services?
How does the adoption of targeted sequencing differ from other services?
The Asia-Pacific NGS services market favors both larger and local manufacturers that compete in multiple segments
Who are the top competitors in this market and what strategies do they employ to gain shares?
What factors are driving growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies look to enter this market use to compete effectively?
What are the major drivers, restraints, challenges, and opportunities, in the global NGS services market?
Who are the major players in various countries and what share of the global market do they hold?
What are the geographical trends and high growth regions/countries?
👉 Get Sample Report with all Graphs & Charts related to it @ https://www.meticulousresearch.com/request-sample-report/cp_id=5041
Email- [email protected]
Contact Sales- +1-646-781-8004